EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL: Plan and Preliminary Results of a Two‐Year Feasibility Trial for a Multicenter Intervention Study to Evaluate the Benefits versus the Disadvantages of Treating Mild Hypertension: Prepared for the Veterans Administration‐National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension†

H. Mitchell Neurath, Anne I. Goldman, Mary Ann Lavin, Harold W. Schnaper, Annette E. Fitz, Edward D. Frohlich, Bernard Steele, Harold G. Richman

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL: Plan and Preliminary Results of a Two‐Year Feasibility Trial for a Multicenter Intervention Study to Evaluate the Benefits versus the Disadvantages of Treating Mild Hypertension: Prepared for the Veterans Administration‐National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension†'. Together they form a unique fingerprint.